Proteasomal inhibition by α-synuclein filaments and oligomers

被引:310
作者
Lindersson, E
Beedholm, R
Hojrup, P
Moos, T
Gai, WP
Hendil, KB
Jensen, PH [1 ]
机构
[1] Aarhus Univ, Dept Med Biochem, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark
[3] Univ So Denmark, Inst Mol Biol, DK-5230 Odense M, Denmark
[4] Univ Copenhagen, Dept Med Anat, DK-2200 Copenhagen, Denmark
[5] Flinders Med Ctr, Dept Physiol, Bedford Pk, SA 5042, Australia
[6] Univ Copenhagen, August Krogh Inst, DK-2100 Copenhagen O, Denmark
关键词
D O I
10.1074/jbc.M306390200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A unifying feature of many neurodegenerative disorders is the accumulation of polyubiquitinated protein inclusions in dystrophic neurons, e. g. containing alpha- synuclein, which is suggestive of an insufficient proteasomal activity. We demonstrate that alpha- synuclein and 20 S proteasome components co- localize in Lewy bodies and show that subunits from 20 S proteasome particles, in contrast to subunits of the 19 S regulatory complex, bind efficiently to aggregated filamentous but not monomeric alpha- synuclein. Proteasome binding to insoluble alpha- synuclein filaments and soluble alpha- synuclein oligomers results in marked inhibition of its chymotrypsin- like hydrolytic activity through a non- competitive mechanism that is mimicked by model amyloid- Abeta peptide aggregates. Endogenous ligands of aggregated alpha- synuclein like heat shock protein 70 and glyceraldehyde- 6- phosphate dehydrogenase bind filaments and inhibit their anti- proteasomal activity. The inhibitory effect of amyloid aggregates may thus be amenable to modulation by endogenous chaperones and possibly accessible for therapeutic intervention.
引用
收藏
页码:12924 / 12934
页数:11
相关论文
共 58 条
  • [1] Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease
    Auluck, PK
    Chan, HYE
    Trojanowski, JQ
    Lee, VMY
    Bonini, NM
    [J]. SCIENCE, 2002, 295 (5556) : 865 - 868
  • [2] Baba M, 1998, AM J PATHOL, V152, P879
  • [3] Impairment of the ubiquitin-proteasome system by protein aggregation
    Bence, NF
    Sampat, RM
    Kopito, RR
    [J]. SCIENCE, 2001, 292 (5521) : 1552 - 1555
  • [4] Mechanisms of chaperone suppression of polyglutamine disease:: selectivity, synergy and medullation of protein solubility in Drosophila
    Chan, HYE
    Warrick, JM
    Gray-Board, GL
    Paulson, HL
    Bonini, NM
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (19) : 2811 - 2820
  • [5] Conformational changes in the 20S proteasome upon macromolecular ligand binding analyzed with monoclonal antibodies
    Conconi, M
    Djavadi-Ohaniance, L
    Uerkvitz, W
    Hendil, KB
    Friguet, B
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 362 (02) : 325 - 328
  • [6] Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. BIOCHEMISTRY, 2000, 39 (10) : 2552 - 2563
  • [7] Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
    Conway, KA
    Lee, SJ
    Rochet, JC
    Ding, TT
    Williamson, RE
    Lansbury, PT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) : 571 - 576
  • [8] Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease
    Conway, KA
    Harper, JD
    Lansbury, PT
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1318 - 1320
  • [9] Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
    Conway, KA
    Rochet, JC
    Bieganski, RM
    Lansbury, PT
    [J]. SCIENCE, 2001, 294 (5545) : 1346 - 1349
  • [10] Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
    Davies, SW
    Turmaine, M
    Cozens, BA
    DiFiglia, M
    Sharp, AH
    Ross, CA
    Scherzinger, E
    Wanker, EE
    Mangiarini, L
    Bates, GP
    [J]. CELL, 1997, 90 (03) : 537 - 548